Group disease with hepatitis B (or A against the background of chronic HBsAg carrier state) may be diagnosed (or excluded) on the basis of high (or low) detectability of HBsAg in patients with jaundice. Perfection of epidemiological diagnosis is possible with implementation of indication of not less than three immunological markers: HBsAg, IgM anti-Hbs, IgM anti-HAV.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[the clinical
4
clinical laboratory
4
laboratory data
4
data differential
4
differential diagnosis
4
diagnosis group
4
group hepatitis
4
hepatitis diseases]
4
diseases] group
4
group disease
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!